Airgain Q2 Revenue Flat at $13.7M, Loss Widens; CEO Adopts 10b5-1 Plan to Sell Up to 72K Shares
AIRG sits 88% above its 52-week low of $3.
Summary
Airgain reported flat Q2 revenue of $13.7M and a net loss of $1.7M. CEO Jacob Suen adopted a 10b5-1 plan to sell up to 72,000 shares starting September 3, 2026. The company also disclosed a separation agreement with its former CTO and continued ATM equity sales.
Key Events · Earnings and Guidance · AIRG
-
Q2 Revenue Flat, Loss Widens
Revenue of $13.7M was essentially flat YoY, while net loss widened to $1.7M from $1.5M. Operating cash burn was $2.6M for the first half, up from $0.9M last year.
-
CEO Adopts 10b5-1 Selling Plan
CEO Jacob Suen adopted a Rule 10b5-1 plan on June 4, 2026 to sell up to 72,000 shares from September 3, 2026 through August 31, 2027. This follows a pattern of heavy insider selling by other officers in recent months.
-
Former CTO Separation Agreement
The company disclosed a separation agreement with former CTO Ali Sadri, effective April 17, 2026, providing $325K in severance and 12 months of accelerated equity vesting.
-
ATM Program Continues to Dilute
Airgain raised $1.0M in net proceeds from the sale of 141,651 shares under its ATM program during Q2, with $2.9M remaining capacity. The program provides liquidity but dilutes existing holders.
Analysis · AIRG · Manufacturing
Airgain's Q2 results show stagnant revenue and a widening net loss, with cash burn accelerating. The CEO's adoption of a 10b5-1 plan to sell up to 72,000 shares adds a negative insider sentiment signal, especially against a backdrop of persistent insider selling over the past 90 days. The separation agreement with the former CTO, including severance and accelerated equity vesting, points to leadership turnover. The company continues to tap its ATM program, raising $1.0M in the quarter, which provides liquidity but dilutes existing shareholders.
At the time of this filing, AIRG was trading at $5.64 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $72.5M. The 52-week trading range was $3.00 to $7.66. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.